CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib

CLL and non-hodgkin lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib Author: cancergrace Added: 06/26/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts